| Literature DB >> 23861553 |
Ya Liu1, Qin Lan, Ling Lu, Maogen Chen, Zanxian Xia, Jilin Ma, Julie Wang, Huimin Fan, Yi Shen, Bernhard Ryffel, David Brand, Francisco Quismorio, Zhongmin Liu, David A Horwitz, Anping Xu, Song Guo Zheng.
Abstract
TGF-β and Foxp3 expressions are crucial for the induction and functional activity of CD4(+)Foxp3(+) regulatory T (iTreg) cells. Here, we demonstrate that although TGF-β-primed CD8(+) cells display much lower Foxp3 expression, their suppressive capacity is equivalent to that of CD4(+) iTreg cells, and both Foxp3(-) and Foxp3(+) CD8+ subsets have suppressive activities in vitro and in vivo. CD8(+)Foxp3(-) iTreg cells produce little IFN-γ but almost no IL-2, and display a typical anergic phenotype. Among phenotypic markers expressed in CD8(+)Foxp3(-) cells, we identify CD103 expression particularly crucial for the generation and function of this subset. Moreover, IL-10 and TGF-β signals rather than cytotoxicity mediate the suppressive effect of this novel Treg population. Therefore, TGF-β can induce both CD8(+)Foxp3(-) and CD8(+)Foxp3(+) iTreg subsets, which may represent the unique immunoregulatory means to treat autoimmune and inflammatory diseases.Entities:
Keywords: CD103; CD8+; Foxp3; TGF-β; regulatory T cells
Mesh:
Substances:
Year: 2013 PMID: 23861553 PMCID: PMC3927769 DOI: 10.1093/jmcb/mjt026
Source DB: PubMed Journal: J Mol Cell Biol ISSN: 1759-4685 Impact factor: 6.216